Pillstats
Rx only · Capsule, Extended Release · Oral

Carbidopa And Levodopa

Brands: Crexont · Rytary · Carbidopa Hydrate + Levodopa

3 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US16 NDCs
3 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
RxCUI (US)6375
US makers3 labelers
Packages30
DEA / ScheduleNone

US acquisition costNADAC · per unit

Average across 12 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.

$1.24$2.47$3.71$4.94Dec 2025Apr 2026Jul 2026
$4.042
Latest avg · Jul 22, 2026
-6%
Since Dec 17, 2025
3
Active US suppliers
87%
Top-2 supplier share*

Medicaid dispensing volumeSDUD · per quarter

Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.

1.0K2.1K3.1K4.2K2025 Q12025 Q22025 Q32025 Q42026 Q1
3.3K
Rx · 2026 Q1
615K
Units dispensed
+0%
Rx vs. year ago
5
Quarters · since 2025 Q1

Who makes it3 active · 0 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
Amneal Pharmaceuticals LLCunknown22SUPPLYING
Zydus Pharmaceuticals USA Inc.unknown4SUPPLYING
REMEDYREPACK INC.repackager4SUPPLYING

Regulatory & supply events

No recalls, shortages, or registration changes on record for this drug concept.